Results showed that for the TCGA-PRAD dataset, those samples with a complete MX1 deletion presented lower mRNA expression, compared with the unaltered samples (diploid) (Figure 3B, right panel). The gene discussed is MX1; the disease is prostate adenocarcinoma.